FYI
"Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharmaust at 35c a share, almost triple its current share price. The total Net Present Value calculated by Redchip for Pharmaust out to 2030 is $56.5m, considerably higher than Pharmaust's current market cap that hovers between $10m and around $12m. "
Full article:
https://www.businessnews.com.au/article/US-research-house-tips-Pharmaust-shares-to-triple?utm
Respected Florida based US research house Redchip, has re-rated ASX listed cancer drug hopeful Pharm
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.5¢ | $274.6K | 1.351M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 86537 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 238021 | 6 |
View Market Depth
| Last trade - 14.02pm 11/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |